Elizabeth Stoner M.D.

Elizabeth Stoner, M.D., is executive partner at MPM Capital and senior clinical advisor of AlloVir, and most recently served as that company’s interim chief medical officer. She has decades of global industry experience and has held several leadership roles at other MPM portfolio companies, including interim CEO of Semma Therapeutics; founder, chief medical officer and chief development officer of Rhythm Pharmaceuticals and chief development officer of Vascular Pharmaceuticals. Prior to joining MPM, Dr. Stoner was senior vice president of Global Clinical Development Operations at Merck Research Laboratories, where she was responsible for clinical development activities in more than 40 countries.